Adjuvant! Genomic 59
ado-trastuzumab emtansine 56
adverse effects see side effects
alcohol consumption 12
anastrozole 52
anatomy 7–8
antiplatelet agents 41
anxiety 67
axillary lymph nodes 19, 24, 30–2, 43–4
bisphosphonates 57
breast-conserving surgery 39, 40, 41–3, 67
carboplatin 55
chemotherapy
cognitive impairment 59
cysts 26
definitions 7
depression 67
diagnosis 17–28
DIEP flap reconstruction 45
diet 12
dimpling of the skin 8, 18, 24
ductal carcinoma 8
ductal carcinoma in situ (DCIS) 7
ELIOT therapy 48
endocrine therapy 36, 51–3, 57
endometrial cancer 52
environmental risk factors 11–12
ER (estrogen receptor)-positive cancer 9, 33, 51–3, 57
everolimus 56
exercise 12
family history 11
fertility 61
fine needle aspiration cytology (FNAC) 20, 25, 26
follow-up 65–6
gene expression profiles 33, 59–60
geographic risk 11
grade of tumor 32
HER2-positive cancer 9, 33, 37, 54–5, 55–6, 57
hormone replacement therapy 12
implants 42
incidence 7
lapatinib 56
letrozole 52
leukopenia 59
lipofilling 45
lobular carcinoma 8
lymph nodes 19, 24, 30–2, 43–4
mammography 13, 17–18, 24–5, 65–6
mammoplasty 42
MammoSite technique 48
mastalgia 18
rehabilitation 66–7
mastopexy 42
menstrual history 11
Mobitron system 48
mortality rates 7
MRI (magnetic resonance imaging) 19, 25–6, 66
mTOR inhibitors 56
multiple tumors 41
nab-paclitaxel 37–8
neoadjuvant therapy 36–8, 44, 48
night work 12
nipple bleeding/discharge 19, 24
nipple conservation 39–40
nipple inversion 24
Nottingham Prognostic Index (NPI) 33
nurse counselors 67
nutrition 12
obesity 12
oral contraceptives 11
osteoporosis 52
ovarian suppression 53
pain, breast 18
pertuzumab 37
phyllodes tumors 8
physical activity 12
physiotherapy 66
poly ADP-ribose polymerase inhibitors 56
premenopausal women 14, 53, 61
prophylactic mastectomy 26, 66
prostheses 66
psychological rehabilitation 67
radiotherapy 36, 43–4, 46–7, 48
reconstructive surgery 40, 44–5
recurrence risk 12, 14, 32, 37, 47, 57
rehabilitation 66–7
reproductive history 11
Scarf–Bloom–Richardson scale 32
screening 17–18
self-examination 18
sentinel lymph nodes 40, 43, 44
side effects
of adjuvant therapies 52, 54, 59, 61
of radiotherapy 46–7
size/shape of the breast 19, 42
skin-sparing mastectomy 39–40
smoking 12
subtypes 33
after an MRI 25–6
rehabilitation 66–7
risks of delay 37
surveillance 65–6
survivorship 65–8
tamoxifen 51–2
TARGIT (intraoperative radiotherapy) 18, 41–2, 47–8
thromboembolism 52
TNM staging 30–2
tomosynthesis 24–5
trastuzumab (Herceptin) 37, 55–6, 57
treatment see chemotherapy; radiotherapy; surgery
triple assessment 19–27
triple-negative cancer 33, 38, 55
vacuum-assisted biopsy 26–7
volunteer groups 67
wide local excision 39, 40, 41–3, 67
Xoft technique 48
You’ve read the book ... now test yourself with key questions from the authors
• Go to the FastTest for this title
FREE at fastfacts.com
• Approximate time 10 minutes
• For best retention of the key issues, try taking the FastTest before and after reading